Revance Therapeutics Merger $17M Securities Settlement

See details

Max Payout

TBD

Filing Deadline

See Details

Proof Required?

A $17 million securities class action settlement has been reached involving Revance Therapeutics and its merger activities. This settlement relates to alleged securities violations in connection with the company's merger. If you owned Revance Therapeutics stock during the relevant time period, you may be entitled to compensation from this settlement. Revance is a biotechnology company that develops and commercializes neuromodulator products for medical and aesthetic applications.

Who Is Eligible?

You may be eligible to file a claim if you:

Purchased or owned Revance Therapeutics stock during the class period (specific dates pending)
Suffered financial losses due to alleged securities violations related to the merger
Meet other eligibility requirements to be determined when full settlement details are available

How Much Can You Get?

The total settlement fund is $17 million. Individual payouts will depend on factors such as the number of shares owned, when you bought and sold them, and your actual losses. The exact payout amounts and calculation methods are still being determined as part of the settlement administration process.

How to File Your Claim

Filing your claim is quick and easy:

Wait for the official claim form and settlement notice to be released
Gather your Revance Therapeutics stock purchase and sale records
Complete the required claim form with accurate transaction information
Submit your claim by the court-approved deadline
Download Class Action Buddy to stay updated on this settlement and get help filing your claim when the form becomes available

💡 Easier way: File with Class Action Buddy

Skip the paperwork. Our app auto-fills your claim form with your saved profile and submits it electronically in under 2 minutes.

Download for iPhone Download for Android

Frequently Asked Questions

What is the Revance Therapeutics securities settlement about?

This is a $17 million settlement related to alleged securities violations in connection with Revance Therapeutics' merger activities. Full details about the specific claims are still pending.

How much money can I get from the Revance settlement?

Individual payouts from the $17 million fund will vary based on your stock ownership, transaction dates, and losses. Specific payout amounts haven't been determined yet.

When is the deadline to file a Revance Therapeutics claim?

The filing deadline has not been announced yet. Class Action Buddy will notify you when the deadline and claim form are available.

Ready to File Your Claim?

We're adding new settlements regularly. Download the app to get notified when this one is available.

Download Class Action Buddy →

Or file directly at the settlement website →